The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

May. 03, 2022
Applicant:

Algen Biotechnologies, Inc., San Francisco, CA (US);

Inventors:

Spencer Charles Knight, San Francisco, CA (US);

Chun-Hao Huang, San Francisco, CA (US);

Assignee:

Algen Biotechnologies, Inc., San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 20/00 (2019.01); G16B 40/20 (2019.01); C12N 5/09 (2010.01); C12N 9/22 (2006.01); C12N 15/10 (2006.01); C12N 15/11 (2006.01); C12N 15/86 (2006.01); G06N 20/00 (2019.01);
U.S. Cl.
CPC ...
G16B 20/00 (2019.02); C12N 5/0693 (2013.01); C12N 5/0694 (2013.01); C12N 9/22 (2013.01); C12N 15/1058 (2013.01); C12N 15/1089 (2013.01); C12N 15/1096 (2013.01); C12N 15/11 (2013.01); C12N 15/86 (2013.01); G06N 20/00 (2019.01); G16B 40/20 (2019.02); C12N 2310/20 (2017.05); C12N 2740/15043 (2013.01); C12N 2800/80 (2013.01);
Abstract

The present disclosure provides methods and systems for identification of genomic regions for therapeutic targeting. A method for identifying one or more genomic regions for therapeutic targeting, which may facilitate re-programming of a cell from one phenotypic state to another, may comprise: providing single-cell RNA-seq data for a plurality of diseased cells and a plurality of normal cells of a cell type; mapping the single-cell RNA-seq data for the plurality of diseased cells and the plurality of normal cells into a latent space corresponding to a plurality of phenotypic states of the cell type; identifying, based at least in part on a topology of the latent space, the one or more genomic regions for therapeutic targeting; and electronically outputting the one or more genomic regions for therapeutic targeting.


Find Patent Forward Citations

Loading…